Latest revenue
$14.0K
as of 2026-03-31
Latest net income
$-8.4M
as of 2026-03-31
Net margin
-59992.9%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $81.0M
- Enterprise value
- $81.0M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $4.09
- 52-wk low
- $1.37
- Beta
- —
- Shares out
- 39.1M
5-year trend
About SERA
Business description and risk factors will appear here once SERA's latest filing is fully ingested.
Profitability
Operating margin
-45066.7%
5.3%Net margin
-39417.3%
7.7%Return on equity
-42.3%
38.5%Return on assets
-31.3%
30.9%Leverage
Debt / equity
0.35×
32.1%Long-term debt / equity
0.00×
100.0%Debt / assets
26.0%
23.8%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $14.0K | -63.2% | $-8.4M | -2.6% | -59992.9% |
Q4 2025 2025-12-31 | $10.0K | -58.3% | $-7.9M | +8.1% | -78810.0% |
Q3 2025 2025-09-30 | $16.0K | -44.8% | $-7.8M | +1.3% | -48837.5% |
Q2 2025 2025-06-30 | $17.0K | -29.2% | $-8.0M | +3.1% | -47329.4% |
Q1 2025 2025-03-31 | $38.0K | — | $-8.2M | -1.1% | -21544.7% |
Q4 2024 2024-12-31 | $24.0K | — | $-8.6M | — | -35745.8% |
Q3 2024 2024-09-30 | $29.0K | -31.0% | $-7.9M | -9.8% | -27306.9% |
Q2 2024 2024-06-30 | $24.0K | -80.5% | $-8.3M | +21.2% | -34595.8% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Medical Laboratories · SIC 8071
Your notes
Keep private notes on SERA — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$842.0K
Net activity
−$842.0K
Distinct insiders
8
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns SERA
Institutional value
$14.7M
Total shares held
7.4M
Distinct holders
26
-31 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | abrdn plc | 2.6M | $5.2M | +271.1K (+11.9%) | Added |
| 2 | PSP Research LLC | 2.4M | $4.9M | — | New |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | $2.4M | — | New |
| 4 | SANDERS MORRIS HARRIS LLC | 314.9K | $639.3K | — | New |
| 5 | BlackRock, Inc. | 196.1K | $398.1K | +9.4K (+5.0%) | Added |
| 6 | VANGUARD FIDUCIARY TRUST CO | 169.7K | $344.4K | — | New |
| 7 | Perigon Wealth Management, LLC | 72.7K | $147.6K | +0 (+0.0%) | No change |
| 8 | Bank of New York Mellon Corp | 60.9K | $123.7K | -14.3K (-19.1%) | Trimmed |
| 9 | JANE STREET GROUP, LLC | 53.9K | $109.4K | -14.9K (-21.7%) | Trimmed |
| 10 | Twelve Points Wealth Management LLC | 43.4K | $88.1K | +0 (+0.0%) | No change |
| 11 | HighTower Advisors, LLC | 42.2K | $85.7K | +0 (+0.0%) | No change |
| 12 | Birch Hill Investment Advisors LLC | 27.3K | $55.4K | +0 (+0.0%) | No change |
| 13 | Cetera Investment Advisers | 25.0K | $50.8K | +0 (+0.0%) | No change |
| 14 | Catalyst Funds Management Pty Ltd | 23.6K | $47.8K | — | New |
| 15 | DIMENSIONAL FUND ADVISORS LP | 19.5K | $39.3K | -3.4K (-14.8%) | Trimmed |
| 16 | UBS Group AG | 14.9K | $30.2K | -10.3K (-41.0%) | Trimmed |
| 17 | Wagner Wealth Management, LLC | 12.4K | $25.2K | -286 (-2.3%) | Trimmed |
| 18 | Vanguard Global Advisers, LLC | 11.2K | $22.7K | — | New |
| 19 | Geneos Wealth Management Inc. | 10.8K | $21.9K | +3.0K (+38.5%) | Added |
| 20 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 10.6K | $21.2K | -81 (-0.8%) | Trimmed |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once SERA's latest filing finishes processing.